These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 12117080)
1. Efficacy of budesonide in moderate to severe asthma. O'Connell EJ Clin Ther; 2002 Jun; 24(6):887-905; discussion 837. PubMed ID: 12117080 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405 [TBL] [Abstract][Full Text] [Related]
4. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
5. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma. Adams N; Bestall JM; Lasserson TJ; Jones PW Cochrane Database Syst Rev; 2004; (2):CD002310. PubMed ID: 15106173 [TBL] [Abstract][Full Text] [Related]
6. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma. Kuna P; Joubert JR; Greefhorst LA; Magnussen H Clin Ther; 2003 Aug; 25(8):2182-97. PubMed ID: 14512127 [TBL] [Abstract][Full Text] [Related]
8. Fluticasone versus beclomethasone or budesonide for chronic asthma. Adams N; Bestall JM; Jones PW Cochrane Database Syst Rev; 2002; (1):CD002310. PubMed ID: 11869636 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of budesonide in inhaled corticosteroid-naive patients and patients with mild persistent asthma. Eigen H Clin Ther; 2002 Jul; 24(7):1035-48. PubMed ID: 12182250 [TBL] [Abstract][Full Text] [Related]
11. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. Dyer MJ; Halpin DM; Stein K BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053 [TBL] [Abstract][Full Text] [Related]
12. Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation. Selroos O; Edsbäcker S; Hultquist C J Asthma; 2004; 41(8):771-90. PubMed ID: 15641626 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. Agertoft L; Pedersen S J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245 [TBL] [Abstract][Full Text] [Related]
14. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children. Adams N; Bestall JM; Lasserson TJ; Jones PW Cochrane Database Syst Rev; 2005 Apr; (2):CD002310. PubMed ID: 15846637 [TBL] [Abstract][Full Text] [Related]
15. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333 [TBL] [Abstract][Full Text] [Related]
16. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma. Morice AH; Hochmuth L; Ekelund J; Thorén A; Puterman AS Pulm Pharmacol Ther; 2008; 21(1):32-9. PubMed ID: 17118686 [TBL] [Abstract][Full Text] [Related]
17. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K; Noonan M; Silkoff PE; Uryniak T Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [TBL] [Abstract][Full Text] [Related]
18. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. Hampel FC; Martin P; Mezzanotte WS J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589 [TBL] [Abstract][Full Text] [Related]
19. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A; Jarvis B Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [TBL] [Abstract][Full Text] [Related]
20. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. FitzGerald JM; Boulet LP; Follows RM Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]